HOME >> BIOLOGY >> NEWS
DNA testing identifies suspect bacteria in coral reef disease

SALT LAKE CITY Using molecular microbiology techniques, scientists are a significant step closer to understanding and identifying the deadly microbes responsible for the mysterious black band disease that is destroying the worlds coral reef ecosystems.

One of the most destructive and widespread of the coral diseases, black band disease is characterized by a ring-shaped bacterial mat that rapidly migrates across a coral colony, leaving dead tissue and bare coral skeleton in its wake.

By sequencing the entire 16S rRNA gene a genetic fingerprint found in all living organisms geologist Bruce Fouke and postdoctoral microbiologist researchers Jorge

Frias-Lopez and George Bonheyo at the University of Illinois at Urbana-Champaign have now identified the main bacteria associated with the black band bacterial mat causing the disease.

The black band microbial mat is dominated by large filamentous cyanobacteria that were previously optically identified as Phormidium corallyticum, Fouke said. Based on the gene sequence analyses, however, we have identified at least three different closely related species of cyanobacteria associated with the bacterial black band mat in different ocean basins around the world.

In earlier work, Fouke and his colleagues showed that the bacteria inhabiting the

black-band disease microbial mat were different from those found either in healthy coral tissue or in the overlaying seawater. That work, which was based upon partial sequencing of bacterial 16S rRNA genes, appeared in the May 2002 issue of Applied and Environmental Microbiology.

To make a more accurate identification of the cyanobacterium inhabiting the black band biomat, the researchers recently collected samples from infected corals on the reef tracts of Papua New Guinea in the Indo-Pacific Ocean and the Netherlands Antilles in the Caribbean Sea. Then they extracted the microbes 16S rRNA gene in their molecular geomicrobiology l
'"/>

Contact: James E. Kloeppel
kloeppel@uiuc.edu
217-244-1073
University of Illinois at Urbana-Champaign
21-May-2002


Page: 1 2 3

Related biology news :

1. Far more men than women favor routine paternity testing at birth
2. Nucleic acid-amplification testing further safeguards nations blood supply
3. Clinical judgement still counts strongly alongside genetic testing
4. Genetic testing of embryos to pick savior sibling OK with most Americans
5. Annual bioethics forum to explore genetic testing
6. New toxicity test could cut animal testing
7. Revised guidelines published for testing for hereditary type of colorectal cancer
8. Study calls for end to age thresholds for prenatal genetic testing
9. Genetic testing of embryos
10. HPV testing could be future strategy for primary screening for cervical cancer
11. High-risk women welcome genetic testing for breast cancer gene

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DNA testing identifies suspect bacteria coral reef disease

(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
(Date:10/14/2014)... October 14, 2014 – High doses of fish oil supplements, ... a common type of irregular heartbeat in which the heart ... results of the AFFORD trial led by the Montreal Heart ... College of Cardiology on October 7th. , For the ... therapy were randomly assigned to 4 grams of fish oil ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: